Choosing injectable therapy: The metabolic fulcrum

Journal of the Pakistan Medical Association

Volumn 66, Issue 7, 2016, Pages 908-909

  Kalra, Sanjay ^a   Gupta, Yashdeep ^b  

^a Bharti Hospital ^*  (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anabolism; Catabolism; Degludec; Detemir; Exenatide qw; Glargine; Glp1ra; Insulin; Liraglutide; Metabolism

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; INSULIN ASPART PLUS INSULIN DEGLUDEC; INSULIN DEGLUDEC PLUS LIRAGLUTIDE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; LIRAGLUTIDE; LIXISENATIDE; ANTIDIABETIC AGENT;

ARTICLE; CACHEXIA; CATABOLISM; CLINICAL DECISION MAKING; DRUG MECHANISM; EUBOLISM; HUMAN; HYPERINSULINEMIA; INJECTABLE THERAPY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALADAPTIVE ANABOLISM; MEDICAL PROCEDURES; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; PATIENT SELECTION;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METABOLISM; PATIENT SELECTION;

EID: 84974795062     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Kalra S, Gupta Y. Choice of Glucose-lowering Therapy- A Metabolic Fulcrum-based Approach. US Endocrinology 2015; 11: 79-80.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2015; 38: 140-149.
3. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan - 2015 - Executive Summary. Endocrine Practice:2015; 21: 413-437
4. Global guideline for type 2 diabetes. Available at: http://www.idf.org/guideline-type-2-diabetes. Last accessed on 23 November 2015
5. Kalra S, Jawad F. Insulin in Ramadan. J Pak Med Assoc, 2015; 65(Suppl 1), S44-S46.